| Immunoregulation by resveratrol; implications for normal tissue protection and tumour suppression AR Lalani, F Fakhari, S Radgoudarzi, N Rastegar‐Pouyani, K Moloudi, ... Clinical and Experimental Pharmacology and Physiology 50 (5), 353-368, 2023 | 30 | 2023 |
| microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance M Fattahi, D Rezaee, F Fakhari, S Najafi, SM Aghaei-Zarch, ... Cell Death Discovery 9 (1), 423, 2023 | 22 | 2023 |
| Synergistic anticancer effects of doxorubicin and metformin combination therapy: A systematic review F Jalali, F Fakhari, A Sepehr, J Zafari, BO Sarajar, P Sarihi, E Jafarzadeh Translational Oncology 45, 101946, 2024 | 9 | 2024 |
| Examining the relationship between per-and polyfluoroalkyl substances and breast, colorectal, prostate, and ovarian cancers: a meta-analysis AH Sezavar, N Rastegar-Pouyani, N Rahimi Kakavandi, F Fakhari, ... Critical Reviews in Toxicology 54 (10), 981-995, 2024 | 1 | 2024 |
| Multi-Target Hybrid Drugs: A Promising Approach for Treating Alzheimer's, Neurological Diseases, Diabetes, and Cancer A Rezagholi Lalani, F Ebrahimbabaie, M Sojoudi, NR Pouyani, ... Journal of Chemical Health Risks, 2023 | 1 | 2023 |
